Pablo Tebas
University of Pennsylvania
H-index: 81
North America-United States
Top articles of Pablo Tebas
Title | Journal | Author(s) | Publication Date |
---|---|---|---|
Immunomodulators for immunocompromised patients hospitalized for COVID-19: a meta-analysis of randomized controlled trials | EClinicalMedicine | Ilias I Siempos Andre C Kalil Drifa Belhadi Viviane Cordeiro Veiga Alexandre Biasi Cavalcanti | 2024/3/1 |
Effects of Pitavastatin on Coronary Artery Disease and Inflammatory Biomarkers in HIV: Mechanistic Substudy of the REPRIEVE Randomized Clinical Trial | JAMA cardiology | Michael T Lu Heather Ribaudo Borek Foldyna Markella V Zanni Thomas Mayrhofer | 2024/2/21 |
Safety and efficacy of doravirine as first-line therapy in adults with HIV-1: week 192 results from the open-label extensions of the DRIVE-FORWARD and DRIVE-AHEAD phase 3 trials | The Lancet HIV | Chloe Orkin Jean-Michel Molina Pedro Cahn Johannes Lombaard Khuanchai Supparatpinyo | 2024/2/1 |
The immunogenicity of an HIV-1 Gag conserved element DNA vaccine in people with HIV and receiving antiretroviral therapy | AIDS | Jeffrey M Jacobson Barbara K Felber Huichao Chen George N Pavlakis James I Mullins | 2022/4/20 |
CCR5-edited CD4+ T cells augment HIV-specific immunity to enable post-rebound control of HIV replication | The Journal of clinical investigation | Pablo Tebas Julie K Jadlowsky Pamela A Shaw Lifeng Tian Erin Esparza | 2021/4/1 |
Bispecific antibodies promote natural killer cell-mediated elimination of HIV-1 reservoir cells | Nature Immunology | Nathan L Board Zhe Yuan Fengting Wu Milica Moskovljevic Meghana Ravi | 2024/1/26 |
Combination of Extended Antivirals With Antiretrovirals for Severe Mpox in Advanced Human Immunodeficiency Virus Infection: Case Series of 4 Patients | Open Forum Infectious Diseases | Michael T Duong Pablo Tebas Bhavya Ancha Jillian Baron Pallavi Chary | 2024/2/27 |
Cognate Antigen Engagement Induces HIV-1 Expression In CD4+ T Cells From People On Long-Term ART | bioRxiv | Milica Moskovjlevic Filippo Dragoni Nathan L Board Fengting Wu Jun Lai | 2024 |
Safety and efficacy of inhaled interferon-β1a (SNG001) in adults with mild-to-moderate COVID-19: a randomized, controlled, phase II trial | EClinicalMedicine | Prasanna Jagannathan Kara W Chew Mark J Giganti Michael D Hughes Carlee Moser | 2023/11/1 |
A prospective 18F-FDG PET/CT study of the neurometabolic effects in cocaine use and HIV infection. | AIDS (London, England) | Ramya S Mamidi Cyrus Ayubcha Grant Rigney Jason Kirschner Oke Gerke | 2023/1/20 |
Susceptibility to 3BNC117 and 10-1074 in ART suppressed chronically infected persons | AIDS | Pablo Tebas Kenn Lynn Livio Azzoni Giorgio Cocchella Emmanouil Papasavvas | 2023/7/1 |
Susceptibility to anti-HIV bnAbs is concordant in pre-ART plasma and on-ART PBMC samples: ACTG NWCS413 | Conference for Retroviruses and Opportunistic Infections. Seattle, WA, USA2019 | Jacqueline Reeves Yu Zheng Maxine Olefsky Yolanda Lie Leah Burke | 2023 |
Participant experiences in HIV cure-directed trial with an extended analytical treatment interruption in Philadelphia, United States | HIV Research & Clinical Practice | Andrea Bilger Eion Plenn Frances K Barg Katharine A Rendle William B Carter | 2023/10/6 |
Phenotypic analysis of HIV-1 resistance to CD4 binding site broadly-neutralizing antibodies | The Journal of Immunology | Hannah Shrader Sabrina Helmold Hait Sarah Lovelace Meaghan Kilner Chen-Hsiang Shen | 2023/5/1 |
The latent reservoir of inducible, infectious HIV-1 does not decrease despite decades of antiretroviral therapy | The Journal of Clinical Investigation | Natalie F McMyn Joseph Varriale Emily J Fray Carolin Zitzmann Hannah MacLeod | 2023/9/1 |
A prospective 18F-fluorodeoxyglucose positron emission tomography/computed tomography study of the neurometabolic effects in cocaine use and HIV infection | AIDS | Ramya S Mamidi Cyrus Ayubcha Grant Rigney Jason Kirschner Oke Gerke | 2023/5/1 |
The Penn Medicine COVID-19 Therapeutics Committee—Reflections on a model for rapid evidence review and dynamic practice recommendations during a public health emergency | George L Anesi Kathleen Degnan Lauren Dutcher Stephen Saw Christina Maguire | 2023/8 | |
Profound phenotypic and epigenetic heterogeneity of the HIV-1-infected CD4+ T cell reservoir | Nature Immunology | Vincent H Wu Jayme ML Nordin Son Nguyen Jaimy Joy Felicity Mampe | 2023/2 |
Cytomegalovirus immunoglobulin G (IgG) titer and coronary artery disease in people with human immunodeficiency virus (HIV) | Clinical Infectious Diseases | Samuel R Schnittman Michael T Lu Thomas Mayrhofer Tricia H Burdo Kathleen V Fitch | 2023/2/1 |
“I know that I was a part of making a difference”: Participant motivations for joining a cure-directed HIV trial with an analytical treatment interruption | AIDS Research and Human Retroviruses | Rebecca Neergaard Nora L Jones Christopher Roebuck Katharine A Rendle Zoe Barbati | 2023/8/1 |